N36(L6)C34 is a recombinant protein that forms a six-helix bundle with high thermal stability. It consists of the N-terminal heptad-repeat region (N36 peptide) and the C-terminal heptad-repeat region (C34) of HIV-1 gp41, connected by six polar amino acids. The protein inhibits HIV-1 envelope-induced membrane fusion. Whether inhibition occurs while N36(L6)C34 is in its six-helix bundle configuration was investigated. Mutating a critical residue within the N36 region to promote dissociation of C34 from the grooves of the N36 coiled coil reduced bundle stability and increased the inhibition of fusion. In contrast, mutating a key residue within the C34 region to reduce bundle stability decreased inhibitory potency. The data provide strong evidence that the proteins inhibit fusion while they expose their C34 segments, rather than as six-helix bundles. Thus, despite high thermal stability of the bundle, the recombinants' less folded structures are present in sufficient concentration to inhibit fusion at physiological temperatures. © 2002 Elsevier Science (USA) 
INTRODUCTION
Fusions between membranes of human immunodeficiency virus type-1 (HIV-1) and a target cell are induced by the envelope protein (Env). HIV Env is a membrane glycoprotein assembled from three identical monomers, with each monomer posttranslationally cleaved into two noncovalently associated subunits-the surface subunit gp120 and the transmembrane subunit gp41 (Wyatt and Sodroski, 1998) . Binding of gp120 to its cellular receptor CD4 and to its coreceptor (a chemokine receptor) induces conformational changes that ultimately allow gp41 to promote membrane fusion in a mechanistic way that is as yet poorly understood (for review see Eckert and Kim, 2001) .
Crystallographic analysis has shown that in the final conformation of gp41, each of the three monomers folds into a hairpin. The amino acid sequences of both the Nand C-terminal portions of a hairpin exhibit heptad-repeats (Chambers et al., 1990; Delwart et al., 1990; Gallaher et al., 1989) . The N-terminal portions of the hairpins combine into a central triple-stranded coiled coil. Each of the C-terminal helices pack into the three grooves of the N-terminal coiled coil in an antiparallel orientation (Chan et al., 1997; Tan et al., 1997; Weissenhorn et al., 1997) .
This trimer of hairpins is referred to as a six-helix bundle (Fig. 1) . Several lines of evidence strongly imply that the six-helix bundle is critically involved in membrane fusion. First, many fusion proteins from different viral families exhibit six-helix bundles as a final structure (Baker et al., 1999; Caffrey et al., 1998; Kobe et al., 1999; Malashkevich, et al., 2001; Skehel and Wiley, 1998; Zhao et al., 2000) . Second, synthetic N-and C-terminal peptides derived from the two heptad-repeat regions of gp41 are inhibitors of HIV infection and membrane fusion (Jiang et al., 1993; Munoz-Barroso et al., 1998; Wild et al., 1994b) . They block fusion by competing with the corresponding heptad-repeat regions of gp41, thereby preventing the formation of the six-helix bundle of gp41 Lu et al., 1995; Weissenhorn et al., 1997) . Third, mutations that destabilize the bundle structure of recombinant soluble forms of gp41 Lu et al., 1999) also impair fusion when introduced into intact HIV Env (Cao et al., 1993; Dubay et al., 1992; Weng et al., 2000; Wild et al., 1994a) .
There has been much speculation as to how the mechanics of six-helix bundle formation effects fusion. The fusion peptide (a hydrophobic N-terminal segment of gp41) is thought to insert into the target membrane prior to fusion (White, 1992) . As the bundles form, the antiparallel orientation of their N-and C-terminal helical segments ( Fig. 1) should bring the fusion peptides in the target membrane and membrane-spanning domains in the viral envelope into close proximity. The viral envelope and target membrane would then also be in close appo-sition. The approach of the fusion peptides and membrane-spanning domains toward each other Hughson, 1997; Weissenhorn et al., 1997) may also directly cause the disruptions of the membranes that are necessary for fusion (Melikyan et al., 2000; Russell et al., 2001) .
High temperatures are required to melt six-helix bundles of gp41 and they are thus very stable (Lu et al., 1995) . But whether formation of a bundle is irreversible under physiological conditions, as a practical matter, remains unknown. Irreversibility would imply a strict sequence of causal events. Recombinant proteins that contain the N-terminal and C-terminal heptad-repeats (referred to as N-segments and C-segments, respectively) separated by a short, hydrophilic, six-residue linker have been produced and shown to fold into thermally stable six-helix bundles Lu and Kim, 1997) . These recombinant core proteins thus provide models for investigating structural and other biophysical properties of six-helix bundles. For example, does a high melting temperature (T m ) ensure that the bundle remains stable at physiological temperatures (which are much lower than T m )? Also, since it is known that these recombinant cores inhibit HIV Env-mediated fusion Lu et al., 1999) , do they inhibit as bundles or as less folded structures in which the C-and N-segments are exposed? If the recombinant proteins are perfectly stable, inhibition of fusion would have to be through a mechanism different from that caused by the binding of isolated N-and C-terminal peptides to their cognate sites on gp41. Inhibition of fusion by the recombinant cores has been investigated, but these prior studies have not been able to provide the mechanism for the inhibition nor answers to the questions posed Shu et al., 2000b) . Because six-helix bundles obviously play a central role in the fusion process, determining the means by which the recombinant cores of the bundle inhibit fusion is key. If they inhibit as six-helix bundles, the recombinant cores could be used experimentally to compete with six-helix bundles of gp41, for example, by preventing the association of gp41 bundles among themselves, an association that has been postulated to be critical for fusion (Hughson, 1997; Weissenhorn et al., 1997) . If, in contrast, C-segments become exposed and bind to gp41, it would mean that a high T m does not imply that bundle formation is irreversible.
In the present study, we devised a strategy to systematically investigate the mechanism by which a recombinant core inhibits HIV-1 Env-mediated fusion. In separate mutations, we altered the N-peptide and the C-peptide to decrease the stability of the recombinant six-helix bundle and we determined how this affected the inhibition of fusion. Our results demonstrate that, despite a high T m , the recombinant bundle can reverse at physiological conditions to expose its C-segments. The exposed segments bind to gp41 and prevent the formation of the gp41 six-helix bundle, thereby blocking fusion by the same mechanism as that of individual C-peptides Chen et al., 1995; Lu et al., 1995) .
RESULTS

Rationale
N36(L6)C34 is a single-chain recombinant core protein that consists of a 36-amino-acid stretch from the Nterminal region (N36) linked to a 34-residue C-peptide (C34) by six polar amino acid residues (L6). N36(L6)C34 associate to form six-helix bundles. We tested whether the recombinant core inhibits HIV Env-mediated fusion while it is in its six-helix bundle form or as an open (dissociated) form. By open form, we mean a structure in which one or more of the C34 segments are not bound within the grooves on the surface of the N36 triplestranded coiled coil. We reasoned that point mutants of N36(L6)C34 with lowered T m , and therefore less stable bundles, would have a higher percentage of protein in an open form than would a wild-type recombinant protein (Figs. 2, 3 ). We used mutations that were within either the C34 or the N36 region. Both types of mutations destabilize the six-helix bundle and thus favor the open structure, but mutations within N36 should lead to more potent inhibition if an open structure is the inhibitory form. This is because C-peptides are much more potent inhibitors than N-peptides (Lu et al., 1995 Wild et al., 1993) . In the open form, the C34 portion of the recombinant protein should bind more avidly than N36 to gp41 and should therefore be responsible for preventing fusion. In short, mutating the N36 segment to reduce bundle stability should better expose the C34 portion and thereby increase the recombinant protein's inhibitory potency. On the other hand, mutating C34 to destabilize the bundle would compromise the ability of C34 to bind to the coiled coil of gp41, and this would decrease the potency of inhibition. If instead of blocking gp41-mediated fusion as an open form the recombinant protein blocked fusion as a six-helix bundle, the potency of inhibition would be reduced by mutations within either the C-or N-terminal portions.
A shorter recombinant protein, N34(L6)C28, has previously been shown to inhibit HIV-1 Env-mediated fusion. Mutations have been made in this recombinant protein and the inhibitory potencies compared to values of T m Shu et al., 2000b) . These studies did not lead to a clear determination for the mechanism of inhibition Shu et al., 2000b) , but they concluded that it was unlikely that the C28 region dissociated from N34 to inhibit fusion and therefore proposed that the recombinant protein inhibited as a six-helix bundle . In this study, we used the longer N36(L6)C34 to test whether inhibition occurs as a bundle for two reasons. First, N36(L6)C34 has a higher melting temperature and its bundle is therefore more stable than that of N34(L6)C28. The greater stability of N36(L6)C34 allows for mutations that would abolish bundles of N34(L6)C28 at experimentally useful temperatures. Second, the open structure of N36(L6)C34 can be detected more readily than that of N34(L6)C28 because C34 is a 10-to 100-fold more potent inhibitor of fusion than is C28 Ji et al., 1999; Lu et al., 1999; Shu et al., 2000b) . These two advantages combine to yield a much greater range of concentrations that inhibit fusion for the larger recombinant protein: The inhibitory concentration of the shorter recombinant protein was less than a factor of two greater than that of the isolated C28 peptide (Shu et al., 2000b) , whereas the inhibitory concentration of the longer recombinant protein was more than two orders of magnitude greater than that of C34. The much larger dynamic range for measurement should further experiments that can reveal the mechanism of inhibition.
The N36(L6)C34 mutants fold into trimeric six-helix bundles
For mutations within N36 we focused on Ile573, generating four mutants by substituting Val, Ala, Ser, and Pro. Residue 573 was chosen because it is at an a position of the heptad-repeat within the interior of the N36 coiled coil and because the hydrophobicity of the Ile side chain is an important determinant of the thermal stability of the six-helix bundle (Jelesarov and Lu, 2001; Lu et al., 1999) . It is also a critical residue for gp41-mediated membrane fusion (Dubay et al., 1992) . The wild-type and four mutants have a large range of conformational stability, allowing a determination of whether the thermal stability of the bundle correlates with the inhibitory activity of the recombinants.
HPLC-purified N36(L6)C34 protein and mutants were solubilized and unfolded with 6 M guanidinium, and then refolded by dilution into neutral pH phosphate-buffered saline (PBS) (see Materials and Methods). On the basis of circular dichroism (CD) measurements in PBS at 4°C, N36(L6)C34 and the I573V, I573A, and I573S variants are well folded, with greater than 90% ␣-helical content (Table 1). Sedimentation equilibrium experiments indicate that each protein exists in a discretely trimeric state across a concentration range from 10 to 100 M ( Fig. 2C ; Table 1 ). The thermal stability of the recombinant core trimers was assessed by CD, monitoring the ellipticity at 222 nm as a function of temperature. Before the unfolding transition, the molar ellipticity is the same for N36(L6)C34 (wild type, WT), I573V, I573A, and I573S and increases linearly with temperature. The steepness of the main transition is very similar for all four molecules, indicating that point mutations at the 573 position do not detectably alter the mechanism of thermal unfolding. At a concentration of 10 M, I573V, I573A, and I573S undergo cooperative and reversible unfolding transitions with midpoints (T m s) of 71, 55, and 51°C, respectively, as compared to a T m of 76°C for the wild type at the same concentration ( Fig. 2B ; Table 1 ). We conclude that the Val, Ala, and Ser substitutions for Ile 573 destabilize the six-helix bundle structure but do not affect its overall protein fold. In contrast, the I573P variant contains ϳ80% ␣-helical structure and unfolds with a T m of 40°C ( Fig. 2B ; Table 1 ). I573P has a tendency to aggregate in solution, as determined by sedimentation equilibrium measurements. The I573P mutation essentially disrupts six-helix bundle formation. Taken together, the CD measurements of T m and equilibrium centrifugation experiments show that the WT recombinant protein and the I573V, I573A, and I573S variants form well-structured, ␣-helical trimers in solution. In the present study we denatured and then refolded the HPLC-purified WT recombinant core and mutants. Without this added procedure, the HPLC-purified recombinant cores tend to aggregate when dissolved in aqueous solution . . The N34 coiled coil is represented as a molecular surface, while the C28 helix (blue) is shown as a ribbon with selected side chains that pack into the N34 interhelical groove. The amino termini of the N34 helices point toward the bottom of the page and those of the C28 helices point toward the top. The figure was prepared with the program GRASP (Nichols, 1991) .
Reducing the stability of the six-helix bundle by mutating the N-terminal segment augments inhibitory activity
We determined the inhibitory activity of N36(L6)C34 and its mutants by fusing effector cells expressing HIV Env to target cells expressing CD4 and CXCR4 in the presence of varying protein concentrations. Effector and target cells, labeled with different fluorescent cytoplasmic dyes, were mixed and preincubated at 23°C for an extended period of time. Dye transfer did not occur between cells at this nonpermissive temperature, but the system did advance toward fusion: after creating this temperature-arrested stage (TAS), fusion was much faster and cells fused more synchronously when the temperature was raised to 37°C than when cells were immediately bound at 37°C without the extended 23°C preincubation (Melikyan et al., 2000) . After TAS was established, recombinants were added and the temperature was then raised to 37°C for 30 min (this is a much shorter time than would be needed for fusion if TAS had not been established). Control experiments showed that when 37°C was maintained for more extended timeswith or without peptides-essentially the same extents of fusion were obtained (data not shown). Our procedure allowed for maximal fusion for the amount of recombinant core present, and the core could bind to gp41 for an extended time after gp41 had undergone some of the conformational changes required for its fusion.
We determined the extent of inhibition of fusion in the presence of WT and its mutants at residue I573 (Fig. 4A) . The inhibitory potencies of all the recombinant cores were weaker than that of synthetic C34 (in the figure represented with crosses) and stronger than that of N36 (filled hexagons), ranging over two orders of magnitude in concentration. There was a perfect correlation of order between the T m of the mutants at position 573 (Table I) and their ability to block cell-cell fusion. This set of data provides strong evidence that the recombinant cores inhibit fusion while their C34 peptides are exposed (open structure). I573S (inverted triangles) and I573P (diamonds) have the lowest melting temperatures, 51 and 40°C, respectively, and were almost as potent at inhibiting fusion as free (isolated synthetic) C34 peptide (Fig.  4A) . The potencies of the recombinant cores must be less than that of synthetic C34 if the cores inhibit fusion as open structures, and this is borne out by the data. (The observed recombinant cores' greater potency of inhibition than that of N36 is not, in principle, required of open structure inhibition because the N36 segment is mutated, so this result does not allow one to distinguish between inhibition mechanisms.) Over the entire concentration range of N36(L6)C34, if aqueous dye transfer was prevented, lipid dye movement was as well (data not shown). That is, the recombinant core did not preferentially inhibit fusion at low concentrations and still permitted hemifusion.
We obtained IC 50 (the concentration that causes 50% inhibition of fusion) by fitting, with a Langmuir isotherm, the data for the extent of fusion as a function of the concentration of inhibitory recombinant cores (Fig. 4B , shown in a linear concentration scale for the most potent cores). The correlation between the stability of the bundle and its ability to inhibit fusion is readily seen by plotting values of IC 50 vs T m for the recombinant cores tested (Fig. 5A) in blocking fusion also varied exponentially with the T m of their six-helix bundles formed with synthetic N36 peptide . For I573P and I573S, which have the least stable bundles, the IC 50 values-2.4 and 6.9 nM, respectively-were close to that of free C34 peptide, which was 2.0 nM. These small differences in IC 50 indicate that a substantial fraction of I573P and I573S are open structures at 37°C, the temperature at which fusion was induced.
We found that the ability of C34 to inhibit fusion was readily reversed upon washing and that inhibition by the recombinant cores was similarly reversible (data not shown). This reversibility means that the unbound recombinant core maintains equilibrium with the fraction that is bound to gp41. If fusion is inhibited by binding of the exposed C34 segment to the coiled coil of gp41, the concentration of open structures should be similar for all recombinants at their IC 50 , all equal to the IC 50 of the isolated C34 peptide. This equality allows the fraction of a recombinant core that is in the open structure to be estimated as the ratio of IC 50 for synthetic C34 peptide to the IC 50 of that recombinant core (Fig. 5B) . The estimate shows that about 80% of I573P and 30% of I573S are open under physiological conditions. This fraction drops steeply for the more stable recombinant cores, down to only 1% for the native N36(L6)C34 at 37°C. If the relationship between IC 50 and T m could be extrapolated to the T m of gp41 (which we take to be 96°C) (Lu et al., 1995) , about 0.1% of gp41 would be open at 37°C.
We performed control experiments to ensure that the inhibition by N36(L6)C34 had not been caused by a contaminant or by a minor fraction of recombinant protein that was misfolded in some way so as to cause the exposure of C34. We added (at 23°C) 2 M of recombinant core to the solution bathing cells that had been brought to TAS in order to bind to gp41 on the cell surface any minor contaminant or misfolded protein that acted as an inhibitor. We then transferred this solution to fresh cells at TAS and again allowed the inhibitory form to bind. This procedure was repeated one more time, the temperature was raised to 37°C, and the extent of fusion was measured. The degree of inhibition of fusion of the cells exposed to recombinant core after the three rounds of preadsorption was similar to that without the transfer procedure. Thus, the open and closed (bundle) conformations of N36(L6)C34 maintained equilibrium, and it is unlikely that a contaminant or minor population of misfolded protein inhibited fusion.
Reducing bundle stability by mutating C-peptide reduces inhibitory activity
We also destabilized the six-helix bundle of N36-(L6)C34 by making substitutions at position I642 of its C34 segment. The T m s of mutants I642A (71°C) and I642S (67°C, Table I) were less than that of the wild type, and both mutants were somewhat less effective in reducing fusion than the wild-type recombinant core (Fig 6,  Table 1 ). The difference in inhibitory efficacy was greatest, and clearly significant, at recombinant protein concentrations of ϳ1 M (Fig. 6) . In contrast to the mutations of I573 within N36, for mutations of I642 within C34 the values of IC 50 varied inversely with T m (Fig. 6, inset) . The mutations of residue I642 promote the opening of the bundle, but the mutated C34 is less able to block fusion than the wild-type sequence. Notably, mutation of the C34 segment has a greater effect on reducing binding to gp41 than on promoting bundle opening. That C34 binding causes the inhibition of fusion is underscored by The fraction of recombinant protein in an open form (a C34 segment is exposed), calculated as the ratio of IC 50 for free C34 to that of the recombinant protein, at 37°C as a function of T m . This calculation assumes that only one of the three possible exposed C34 segments per trimer of recombinant core inhibits fusion. Alternatively, the open structure could expose three C34 segments and each segment could inhibit independently of the other two. The percentage of a recombinant core in an open structure would then be one-third of our estimate. Our estimate should be the maximum percentage of trimeric recombinant cores that are in open structures. We consider it likely that only one exposed C34 segment of each recombinant core can inhibit fusion because binding of one segment should constrain the possible orientations of the other two; the linker between the N36 and C34 segments is relatively short, being only six amino acid residues in length.
the 10-fold lower value of IC 50 for I573V than for I642A, even though both mutants have roughly the same T m . The inhibitory activity of the open structure is thus primarily conferred by the exposed C34 segment; exposed N36 is of significantly less consequence.
DISCUSSION
Small amounts of open forms can inhibit fusion
Our data yield straightforward evidence that N36(L6)-C34 blocks gp41-mediated fusion as an open structure with its C34 segment exposed. The high thermal stability (i.e., the high T m ) of the six-helix bundle might imply that its dissociation into an open form would be so negligible at physiological temperatures that the observed inhibition must be caused by the recombinant six-helix bundle. However, this is fallacious for several reasons. First, values of T m are typically quoted for higher concentrations (ϳ10 M) of recombinant proteins than are needed (well below 1 M) to block fusion in our system (Fig. 4) . The value of T m decreases with decreasing concentration of recombinant proteins (Jelesarov and Lu, 2001) . Second, C-peptides inhibit fusion through a dominantnegative mechanism Lu et al., 1995; Weissenhorn et al., 1997) . Because more than one copy of Env is undoubtedly required to generate a fusion pore, fusion will depend steeply on the density of functional Env. As a consequence, small amounts of open structures of the recombinants can block fusion. Functional assays for fusion can detect the presence of these open structures, whereas biochemical detection is difficult. We estimate that somewhat less than 0.1% of the recombinant in an open form can be detected by inhibition of fusion.
Mutations in the C34 segment result in competing effects: destabilization of the bundle (which decreases IC 50 ) and reduction of the inhibitory efficacy of the exposed C34 segment. IC 50 increased as T m was reduced for mutations at position 642 of the C-peptide (Fig. 6,  inset) , showing that the reduced efficacy of the exposed C34 segment in blocking fusion is the more consequential effect. These competing effects result in an increase (twofold) in IC 50 for a mutation in the C34 segment smaller than the decrease (fourfold) in IC 50 for a mutation at position 573 of the N36 segment (for every 10°C decrease in T m caused by mutation). The larger quantitative effect for mutations in the N-peptide region is expected because the only effect of mutations in the N36 segment is to destabilize the bundle. It was found in a prior study that for every decrease in T m of 10°C for mutations within the C34 peptide (corresponding to position 631), IC 50 increased sevenfold . This increase in IC 50 greater than that caused by mutations within the C34 segment of the recombinant core is expected because a mutation within the C34 segment that promotes open structures must also reduce the binding affinity of the exposed segments to the grooves of the coiled coil of gp41.
If a single C-segment were to dissociate from the coiled coil, the vacated groove on the coiled coil could, in principle, inhibit fusion if it then bound C-terminal segments of gp41. A five-helix peptide consisting of three N-peptides and two C-peptides arranged in a single chain has, in fact, recently been found to inhibit fusion (Root et al., 2001) . The N-peptides fold into a coiled coil and the presence of only two C-peptides results in one vacant groove on the coiled coil. Since C34 is about 20-fold more potent than this five-helix peptide, C34 that has dissociated from the bundle of N36(L6)C34, rather than the presence of vacant grooves, should be the major contributor to the inhibition of fusion.
Correlation between the stability of the six-helix bundle and its inhibitory activity for N34(L6)C28
Prior studies, using the shorter N34(L6)C28 and mutants, yielded data that were not fully consistent with the recombinant protein inhibiting fusion as either a six-helix bundle or as an open structure Shu et al., 2000b) . In reviewing all of the prior data, we are now able to analyze and interpret much of it in accord with our proposed mechanism. In the cases of those mutants of N34(L6)C28 whose data we could not reconcile with our interpretation, we conducted new fusion experiments ourselves (Fig. 7B ). With these new experiments, we can now provide a cohesive view of fusion inhibition.
We made a plot of the data from previous studies for inhibition of fusion by N34(L6)C28 and its mutants Shu et al., 2000b) and it shows that IC 50 and T m did not correlate (Fig. 7A) . However, we can see from our plot that a correlation can be made for the mutants with values of T m greater than the temperature used to induce fusion (37°C), with the exception of Q652L (a mutation in the C28 segment; Fig. 7A, open triangle) . The Q652L anomaly can be explained, however, by the greater potency of the mutated C28 segment when it is exposed: when Q652 was substituted by L652 in synthetic C28, the IC 50 decreased by about a factor of four (Shu et al., 2000b) . For the mutants with T m Ͻ 25°C (Fig. 7A, points within box), the absence of a correlation is not surprising; most of the recombinant proteins would be unfolded and this would tend to lead to aggregation. Aggregation, made more likely by the high concentrations used in the prior studies (see legend to Fig. 7) , would render them less active. The recombinant mutant proteins that do correlate all have relatively high values of T m (Ͼ50°C). However, for these mutants the recombinant proteins are more potent inhibitors of fusion, on a mole basis, than isolated C28 peptide, and this result cannot be explained by either of the two mechanisms. On the one hand, the correlation is the reverse of what should occur if the recombinant protein inhibits as a bundle; on the other hand, recombinant proteins cannot inhibit fusion with a potency greater than that of isolated C-peptides if the exposed C-segments of open structures are the inhibiting agent (assuming that only one C-peptide per open structure can inhibit).
Because these previous studies led to inconsistencies, we measured, in our system, the inhibitory potencies of the anomalously effective recombinant proteins W571R and L568A/W571R as well as Q652L and C28. We found that the order of potencies still correlated as in the previous studies, but that C28 inhibited fusion more effectively than any of these recombinants, except for L568A/W571R (Fig. 7B, open circle, experimental) . This may indicate that L568A/W571R dissociates into monomers and that its open structure is three monomers rather than a trimer. If this double mutant (having both mutations within the coiled coil) with a relatively low T m were to completely dissociate into monomers and thereby expose all three of its C28 segments, the effective concentration of the inhibitory segments would be three times that of the recombinant protein concentration. If it did dissociate into three monomers, inhibition by this mutant (Fig. 7B, filled circle) would be less effective, on a mole basis, than that of C28. Thus, a critical analysis of the data favors the conclusion that N34(L6)C28 inhibits fusion in an open form because the correlation for mutations within N34 (that do not lower T m to an extent that would cause recombinant aggregation) shows that the more likely it is for C28 to become exposed, the better it is as an inhibitor. The anomalous potency of the Q652L mutant actually strengthens this conclusion by showing that the more potent the inhibition by free C-peptide, the greater the inhibition by the recombinant protein. Moreover, all of the data lead to the conclusion that equilibrium is maintained between bundles and open structures.
Implications for gp41-mediated fusion
The high thermal stability (T m Ն 90°C) of the six-helix bundle formed by a water-soluble fragment of the gp41 ectodomain (Lu et al., 1995; Weissenhorn et al., 1996) indicates that (on the time scale of the Env-mediated Ji et al., 1999; Shu et al., 2000) . The recombinant protein with the mutation Q652L in C28 stabilizes the bundle (open triangle). The three mutants with the lowest values of T m (all containing the mutation I573S) are enclosed in a square. (The T m for the triple mutant L568A/W571R/I573S was measured to be Ͻ20°C ; the arbitrary value of 15°C was assigned to this plot.) For the other mutants, connected by the solid line, IC 50 and T m correlated. However, some of the mutant recombinant proteins that exhibit the expected correlation were measured to be more potent inhibitors of fusion than C28, which would run counter to inhibition as an open structure. (B) Several of the anomalously potent N34(L6)C28 mutants were retested and exhibited the same order of potency for the stable cell lines as that previously reported for the infected cells. However, in contrast to the previous reports, W571R was less potent at inhibiting fusion than C28. The double mutant L568A/W571R (experimental) was still somewhat more potent. In the extreme case of dissociation into monomers, it would be a less potent inhibitor than C28. Note that the N34(L6)C28 recombinant proteins and the isolated peptides were more than 10-fold less effective in blocking fusion in the previous studies than found with our cells. The differences in concentration are probably due to the use of HIV-infected cells in the prior studies Shu et al., 2000b) as opposed to the stably transfected cells in our study. Because acutely infected cells should express higher levels of Env than stably transfected cells, fusion should be more difficult to inhibit with infected cells. fusion process) once bundles form, the fraction that dissociates is negligible. But it has been argued that sixhelix bundles of proteins that model the core of gp41 readily dissociate into monomers when they interact with membranes, despite the stability in solution (Kliger et al., 2000) . This claim contrasts with the finding that the bundle of N34(L6)C28 resists dissociation by detergent and by liposomes (Shu et al., 2000a) . Also, antibodies that specifically recognize the six-helix bundle structure have increased binding after the addition of soluble CD4 to HIV Env-expressing cells (de Rosny et al., 2001; Jiang et al., 1998) . This finding indicates that the gp41 bundle did not dissociate within the lipid bilayer. (Soluble CD4 caused shedding of gp120 from gp41 for the cells used in those studies, and therefore the gp41 folded into a bundle via an inactivation pathway.)
Whether formation of a bundle by gp41 is irreversible is of great importance for understanding the mechanism of viral fusion. Any stabilization of the bundle by structural features of a trimer, such as the disulfide-bonded loop between the N-and C-heptad repeats, should be reflected in the measured T m of the ectodomain of gp41. Factors that would not contribute to the melting temperature but that could stabilize the bundle would include the reduced degrees of freedom for a protein anchored to membranes (through its membrane-spanning domain in the viral membrane and through insertion of the fusion peptides into the target membrane) Melikyan et al., 2000; Weissenhorn et al., 1997) .
Fusion proteins concentrate during the fusion process sufficiently to be chemically cross-linked (Markovic et al., 1998) , but it is not known whether there are specific protein-protein interactions between them. N36(L6)C34 does not inhibit fusion as a six-helix bundle, even though the overwhelming majority of the recombinant protein has this structure at 37°C. Whatever the function of a six-helix bundle of gp41, it is unlikely that the bundle is required to interact with another bundle or with other portions of proteins, since the added recombinant bundles did not inhibit fusion. We thus conclude that if multiple copies of gp41 associate during the fusion process, they do so through interactions between regions of the protein that do not include the six-helix bundle.
MATERIALS AND METHODS
Recombinant protein production and purification
Mutations were introduced into the recombinant N36(L6)C34 core protein that models the gp41 ectodomain (Lu and Kim, 1997) using the method of Kunkel (1987) and verified by DNA sequencing. N36(L6)C34 consists of residues 546-581 (N36) and 628-661 (C34) of Env joined by a linker of six hydrophilic residues. All N36(L6)C34 variants were recombinantly expressed in Escherichia coli strain BL21(DE3)/pLysS (Novagen, Madison, WI). Cells were grown at 37°C in LB medium to an optical density of 0.8 at 600 nm and induced with isopropyl ␤-D-thiogalactoside for 3 to 4 h. Cells were lysed at 0°C by glacial acetic acid. The bacterial lysate was centrifuged (35,000 g for 30 min) to separate the soluble fraction from inclusion bodies. The soluble fraction, containing denatured recombinant protein, was dialyzed into 5% acetic acid overnight at room temperature. Recombinant proteins were purified from the soluble fraction to homogeneity by reverse-phase HPLC (Waters, Inc., Milford, MA) on a Vydac C-18 preparative column, using a water-acetonitrile gradient in the presence of 0.1% trifluoroacetic acid, and lyophilized. Purified proteins were solubilized in 6 M guanidinium hydrochloride (and 50 mM sodium phosphate (pH 7.0) and refolded by dilution into neutral pH PBS. The N36 and C34 peptides were synthesized by solid-phase fluorenylmethoxycarbonyl peptide chemistry and had an acetylated amino terminus and an amidated carboxyl terminus. After cleavage from the resin, peptides were desalted with a Sephadex G-25 column (Amersham, Pharmacia Biotech, Piscataway, NJ) and purified by HPLC as described above. Peptide identities were confirmed by matrix-assisted laser-desorption ionization mass spectrometry (Voyager Elite, PerSeptive Biosystems, Cambridge, MA). Peptide concentrations were measured by absorbance at 280 nm in 6 M guanidinium hydrochloride (Edelhoch, 1967) . Stock solutions of 200-600 M of the peptides in water were prepared, frozen in aliquots, and stored at -20°C. Control experiments demonstrated that the inhibitory activity of these peptides was not affected by freezing.
Circular dichroism spectroscopy
CD experiments were performed on an Aviv 62A DS circular dichroism spectrometer. The wavelength dependence of molar ellipticity, [], was monitored at 4°C for a 10 M protein solution in 50 mM sodium phosphate, pH 7.0, and 150 mM NaCl (PBS). Helix content was calculated as described (Chen et al., 1974) . Thermal stability was determined by monitoring the change in [] 222 as a function of temperature. Thermal melts were performed in 2°C increments with an equilibration time of 120 s at the desired temperature and an integration time of 30 s. All melts were reversible. Superimposable folding and unfolding curves were observed, and Ͼ85% of the signal was regained upon cooling. The midpoint of the thermal unfolding transition (T m ) was determined from the maximum of the first derivative, with respect to the reciprocal of the temperature, of the [] 222 values (Cantor, 1980) . The error in estimation of T m is Ϯ0.5°C.
Sedimentation equilibrium
Sedimentation equilibrium experiments were performed on a Beckman XL-A analytical ultracentrifuge (Beckman Instruments, Fullerton, CA) using an An-60 Ti rotor. Protein solutions were dialyzed overnight against PBS (pH 7.0), loaded at initial concentrations of 10, 30, and 100 M, and analyzed at rotor speeds of 20,000 and 23,000 rpm at 20°C. Data sets were fitted simultaneously to a single-species model of ln(absorbance) versus (radical distances) 2 using the program NONLIN (Johnson et al., 1981) . Protein partial specific volume and solvent density were calculated as described (Laue et al., 1992) . The molecular weights of N36(L6)C34 and its variants, except for I573P, were all within 10% of those calculated for an ideal trimer, with no systematic deviation of the residuals.
Cell maintenance
Cells stably expressing HIV-1 Env from BH10 strain (TF228.1.16) were obtained from Dr. Zdenka Jonak (SmithKline Beecham, Philadelphia, PA) and grown in suspension in RPMI 1640 supplemented with 10% Cosmic Calf serum (HyClone Laboratories, Logan, UT). The target cells (HeLaT4 ϩ ) expressing CD4 and CXCR4 (Maddon et al., 1986) were obtained from the NIH Research and Reference Reagent Program. HeLaT4 ϩ cells were maintained in DMEM supplemented with 10% Cosmic Calf serum and 0.5 mg/ml of G418 sulfate (Mediatech Inc., Herndon, VA).
Cell labeling and cell-cell fusion assay
About 7 ⅐ 10 6 effector TF228.1.16 cells were labeled with 2.5 M of cytoplasmic dye calceinAM, and slightly subconfluent target HeLaT4 ϩ cells on 6-cm dishes (ϳ4 ϫ 10 6 cells) were labeled with 80 M of CellTracker Blue, CMAC (both dyes were from Molecular Probes, Eugene, OR), as described (Melikyan et al., 2000) . The target and effector cells were mixed at a 1:1 ratio, resuspended in HEPES-buffered DMEM (GIBCO BRL, Gaithersburg, MD) supplemented with 0.1% BSA (Sigma Chemical Co., St. Louis, MO) at 10 6 cells/ml, and immediately transferred into a polylysine-coated eight-chambered slide (Lab-Tek, Nalge Nunc International, Naperville, IL). The effector and target cells adhered to the polylysine and randomly established contacts with each other. The chosen cell density favored contacts and fusion between cell pairs. The effector and target cells were coincubated for 2.5 h at 23°C, after which time different concentrations of inhibitory recombinant proteins and peptides dissolved in DMEM-0.1%BSA solution were added to the wells. Proteins and peptides were allowed to bind for 30 min at 23°C, followed by incubation at 37°C for 30 min. As a result of fusion, cells became stained with both calceinAM (green emission) and CMAC (blue emission). Fusion was quantified under a Leitz Laborlux D fluorescent microscope by calculating the fraction of effectortarget cell contacts that had fused in each field, as described (Melikyan et al., 2000) . About 100 cell pairs were screened per well and at least four independent experiments in duplicates were carried out to determine the extent of fusion for a given peptide concentration.
